Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen presentation and DNA vaccines.

J J Donnelly1, M A Liu, J B Ulmer

  • 1Department of Vaccines and Gene Therapy Research, Chiron Corporation, Emeryville, California, USA.

American Journal of Respiratory and Critical Care Medicine
|October 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA vaccines.

Methods in molecular medicine·2011
Same author

A Modified ELISA for Measurement of High-Avidity IgG Antibodies to Meningococcal Serogroup C Polysaccharide that Correlate with Bactericidal Titers.

Methods in molecular medicine·2011
Same author

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Vaccine·2010
Same author

Public health. The cholera crisis in Africa.

Science (New York, N.Y.)·2009
Same author

Topic in Review: Vaccines in the 21st century.

The Western journal of medicine·2008
Same author

Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer.

Scandinavian journal of immunology·2007

Both cross-priming and direct transfection of antigen-presenting cells (APCs) aid DNA vaccine immune responses. Enhancing both pathways is key to increasing DNA vaccine potency and effectiveness.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • DNA vaccines induce immune responses through antigen-presenting cell (APC) interactions.
  • Both cross-priming and direct APC transfection are implicated in DNA vaccine efficacy.
  • The relative importance of these pathways for cytotoxic T cell responses remains unclear.

Purpose of the Study:

  • To explore strategies for enhancing DNA vaccine potency.
  • To investigate methods for facilitating both cross-priming and direct APC transfection pathways.
  • To identify key factors for optimizing DNA vaccine-induced immune responses.

Main Methods:

  • Review of current scientific literature on DNA vaccine mechanisms.
  • Analysis of antigen transfer, APC targeting, and immune cell recruitment strategies.

Related Experiment Videos

  • Exploration of DNA formulations and delivery systems for enhanced APC uptake.

    • Main Results:

    • Both cross-priming and direct APC transfection are sufficient for immune induction, but neither is essential alone.
    • Understanding antigen transfer and APC interactions can guide vaccine design.
    • Targeting APCs and optimizing their activation state are crucial for priming.

    Conclusions:

    • A dual approach, enhancing both cross-priming and direct APC transfection, is a rational strategy for increasing DNA vaccine potency.
    • Further research into APC targeting, antigen presentation, and immune cell manipulation is warranted.
    • Significant scientific effort is ongoing to optimize DNA vaccine performance.